Nevro Corp. logo
Nevro Corp. NVRO

Annual report 2024
added 03-04-2025

report update icon

Nevro Corp. Balance Sheet 2011-2026 | NVRO

Annual Balance Sheet Nevro Corp.

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

93.4 M 113 M 71.7 M 121 M 101 M 267 M 314 M 329 M 332 M 39.3 M 146 M -12.4 M -5.62 M -

Long Term Debt

188 M 211 M 187 M 151 M 142 M 160 M 152 M 145 M 138 M 19.7 M 19.5 M - - -

Long Term Debt Current

318 K 5.72 M 5.2 M 4.59 M 3.88 M 3.5 M - - - - - - - -

Total Non Current Liabilities

- - - - - 183 M 155 M 147 M 139 M 20.2 M 19.6 M 62 K 248 K -

Total Current Liabilities

103 M 83.4 M 79.2 M 82.2 M 239 M 70.6 M 62.4 M 58 M 42.2 M 36.4 M 10.8 M - - -

Total Liabilities

323 M 343 M 279 M 271 M 401 M 253 M 218 M 205 M 182 M 56.6 M 30.4 M 7.97 M 5.5 M -

Retained Earnings

-813 M -699 M -607 M -624 M -493 M -410 M -306 M -258 M -221 M -189 M -122 M -91.2 M -65 M -

Total Assets

554 M 636 M 602 M 575 M 789 M 470 M 463 M 454 M 431 M 291 M 202 M 75.4 M 49.1 M -

Cash and Cash Equivalents

94.5 M 104 M 120 M 34.7 M 44.6 M 65.4 M 51.3 M 42.8 M 41.4 M 87 M 25.3 M 12.4 M 5.62 M -

Book Value

231 M 293 M 324 M 304 M 388 M 216 M 245 M 249 M 249 M 235 M 172 M 67.4 M 43.6 M -

Total Shareholders Equity

231 M 293 M 324 M 304 M 388 M 216 M 245 M 249 M 249 M 235 M 172 M -85.8 M -61.8 M -

All numbers in USD currency

Quarterly Balance Sheet Nevro Corp.

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

184 M 181 M 215 M 211 M 188 M 187 M 187 M 187 M 187 M - 186 M 151 M 149 M 146 M 144 M 142 M 142 M 142 M 142 M 160 M 160 M 160 M 160 M 152 M 152 M 152 M 152 M 145 M 145 M 145 M 145 M 138 M 138 M 138 M 138 M 19.7 M 19.7 M 19.7 M 30.8 M 31.3 M - - - - - - - - - - - - - - -

Total Liabilities

322 M 329 M 318 M 343 M 276 M 275 M 273 M 279 M 281 M - 292 M 271 M 263 M 241 M 409 M 401 M 401 M 401 M 401 M 253 M 253 M 253 M 253 M 218 M 218 M 218 M 218 M 205 M 205 M 205 M 205 M 182 M 182 M 182 M 182 M 56.6 M 56.6 M 56.6 M 56.6 M 30.4 M 30.4 M 30.4 M 30.4 M 7.97 M 7.97 M - - - - - - - - - -

Retained Earnings

-760 M -744 M -725 M -699 M -690 M -667 M -642 M -607 M -588 M - -645 M -624 M -594 M -544 M -522 M -493 M -493 M -493 M -493 M -410 M -410 M -410 M -410 M -306 M -306 M -306 M -306 M -258 M -258 M -258 M -258 M -221 M -221 M -221 M -221 M -189 M -189 M -189 M -189 M -122 M -122 M -122 M -122 M -91.2 M -91.2 M - - - - - - - - - -

Total Assets

596 M 603 M 596 M 636 M 562 M 570 M 574 M 602 M 606 M - 533 M 575 M 582 M 600 M 776 M 789 M 789 M 789 M 789 M 470 M 470 M 470 M 470 M 463 M 463 M 463 M 463 M 454 M 454 M 454 M 454 M 431 M 431 M 431 M 431 M 291 M 291 M 291 M 291 M 202 M 202 M 202 M 202 M 75.4 M 75.4 M - - - - - - - - - -

Cash and Cash Equivalents

72 M 74.7 M 90.3 M 104 M 65.2 M 65.2 M 64.2 M 120 M 131 M - 49.5 M 34.7 M 80.9 M 146 M 86.5 M 44.6 M 44.6 M 44.6 M 44.6 M 65.4 M 65.4 M 65.4 M 65.4 M 51.3 M 51.3 M 51.3 M 51.3 M 42.8 M 42.8 M 42.8 M 42.8 M 41.4 M 41.4 M 41.4 M 41.4 M 87 M 87 M 87 M 87 M 25.3 M 25.3 M 25.3 M 25.3 M 12.4 M 12.4 M - - 5.62 M - - - 11.3 M - - -

Book Value

274 M 274 M 279 M 293 M 286 M 295 M 301 M 324 M 325 M - 240 M 304 M 319 M 358 M 366 M 388 M 388 M 388 M 388 M 216 M 216 M 216 M 216 M 245 M 245 M 245 M 245 M 249 M 249 M 249 M 249 M 249 M 249 M 249 M 249 M 235 M 235 M 235 M 235 M 172 M 172 M 172 M 172 M 67.4 M 67.4 M - - - - - - - - - -

Total Shareholders Equity

274 M 274 M 279 M 293 M 286 M 295 M 301 M 324 M 325 M 230 M 240 M 304 M 319 M 358 M 366 M 388 M 388 M 388 M 388 M 216 M 216 M 216 M 216 M 245 M 245 M 245 M 245 M 249 M 249 M 249 M 249 M 249 M 249 M 249 M 249 M 235 M 235 M 235 M 235 M 172 M 172 M 172 M 172 M -85.8 M -85.8 M - - -61.8 M - - - -44.7 M - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Nevro Corp., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 62.59 -0.37 % $ 92.7 B usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 12.07 0.33 % $ 1.63 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.59 1.2 % $ 36.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.7 0.73 % $ 347 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.45 1.77 % $ 129 M franceFrance
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 81.19 0.17 % $ 47.5 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.6 0.05 % $ 122 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.13 0.49 % $ 874 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 36.74 -0.05 % $ 5.47 K usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
AxoGen AxoGen
AXGN
$ 32.64 -5.23 % $ 1.5 B usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 1.9 2.15 % $ 1.15 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.31 -2.31 % $ 717 M usaUSA
Inogen Inogen
INGN
$ 6.36 2.42 % $ 169 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.0 1.66 % $ 16.9 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 95.66 -0.59 % $ 1.22 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 85.63 -1.4 % $ 2.97 B usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Align Technology Align Technology
ALGN
$ 171.87 0.74 % $ 12.9 B usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.94 -0.75 % $ 374 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
LENSAR LENSAR
LNSR
$ 5.89 -2.81 % $ 70.4 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 9.38 0.11 % $ 266 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.36 2.26 % $ 55.3 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 86.28 -0.4 % $ 111 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 3.88 -1.02 % $ 573 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Myomo Myomo
MYO
$ 0.7 4.84 % $ 29.3 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 11.77 2.08 % $ 466 M curacaoCuracao
PAVmed PAVmed
PAVM
$ 10.04 1.93 % $ 6.73 M usaUSA